Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2025-02-12 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
关于公司年产3万吨年丙交酯搬迁项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a specific project investment and relocation by the company 中粮生物科技股份有限公司. It details the project name, investment amount, construction period, location, necessity, feasibility, and potential impact on the company. There are no financial statements, quarterly or annual results, or audit information. The document is relatively short (1121 characters) and serves as a formal public announcement about a capital investment project. This fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes, specifically a major project investment and relocation. It is not an annual report, earnings release, or regulatory filing. Therefore, the classification is CAP with high confidence.
2025-02-12 Chinese
九届董事会2025年第2次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2025 second extraordinary meeting of the 9th Board of Directors of 中粮生物科技股份有限公司. It details the attendance, voting results, and the agenda item approved (relocation of a production project). It references that detailed content is available on other platforms but does not itself contain detailed financial data or comprehensive management discussion. The document is short (815 characters) and serves as a board meeting resolution announcement rather than a full management or financial report. Therefore, it fits best under Board/Management Information (MANG).
2025-02-12 Chinese
2025年第1次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2025 first extraordinary shareholders' meeting of the company. It details the meeting date, attendance, voting results on a specific proposal, and includes a legal opinion confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official announcement of the voting results from the shareholders' meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2025-02-06 Chinese
2025年第1次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2025 first extraordinary general meeting (EGM) of shareholders of a company. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes. It does not contain financial statements or management discussion of financial results, nor is it a report or announcement of financial results. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's legality and procedures. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal document related to corporate governance and shareholder meetings but does not fit other more specific categories.
2025-02-06 Chinese
关于召开公司2025年第1次临时股东大会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the convening of the 2025 first extraordinary general meeting (临时股东大会) of COFCO Bio-chemical Co., Ltd. It includes information on the meeting date, voting procedures (both in-person and online), agenda items, registration details, and proxy voting instructions. The document does not contain financial statements or results but serves as a notice to shareholders about the meeting and how to participate and vote. It is not a report of voting results, nor is it a proxy solicitation statement or a management report. Given the content and purpose, this document fits the category of a shareholder meeting notice or announcement. The closest matching filing type in the provided list is "Declaration of Voting Results & Voting Rights Announcements (DVA)" for voting results, but this document is a pre-meeting notice, not results. It is also not a Proxy Solicitation & Information Statement (PSI) because it does not solicit votes with detailed information but rather announces the meeting and voting logistics. Therefore, the best fit is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. The document length (4808 characters) and detailed procedural content support this classification.
2025-01-23 Chinese
公司2025年度向招行申请授信、融资事项的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the company's application for credit and financing with a bank. It details the intent to establish a credit line and financing terms but does not contain financial statements or detailed financial data. The document length is only 431 characters, indicating it is a brief announcement rather than a full report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2025-01-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.